PB1938: REAL WORLD EFFECTIVENESS AND SAFETY OF VENETOCLAX IN COMBINATION WITH OBINUTUZUMAB IN TREATMENT NAIVE CLL PATIENTS – DATA FROM THE OBSERVATIONAL STUDY VERVE

• Ingo Schwaner,
• Holger Hebart,
• Losem Christoph,
• Wolff Thomas,
• Schmidt Burkard,
• Davide Rossi,
• Lehmann Caroline,
• Benzel Julia,
• Huelsenbeck Johannes,
• Pichler Petra

Affiliations

Ingo Schwaner

1 1Onkologie Kurfürstendamm, Berlin, Germany, Germany

Holger Hebart

2 2Kliniken Ostalb, Mutlangen, Germany

Losem Christoph

3 3TZN Tumorzentrum Niederrhein GmbH, Germany

Wolff Thomas

4 Onkologie Lerchenfeld, Hamburg, Germany

Schmidt Burkard

5 Hämatologisch-Onkologische Gemeinschaftspraxis, München, Germany

Davide Rossi

6 Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland

Lehmann Caroline

7 AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany

Benzel Julia

7 AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany

Huelsenbeck Johannes

7 AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany

Pichler Petra

8 Department of Internal Medicine I, University Hospital St. Poelten, Karl Landsteiner University of Health Sciences, St. Poelten, Austria